Selected References:
- Brooks C, et al. 1977. Linear growth of children with limb deformities following exposure to thalidomide in utero. Acta Paediatr Scan, 66:673-675.
- Castilla E, et al. 1996. Thalidomide, a current teratogen in South America. Teratology, 54:273-277.
- Gao S, et al. 2020. Recent advances in the molecular mechanism of thalidomide teratogenicity. Biomed Pharmacother, 127:110114.
- Guo L, et al. 2023. Inflammatory bowel disease can reduce ovarian reserve function in women: a systematic review and meta-analysis. Medicine (Baltimore), 102(11):e33113.
- Gollop T, et al. 1987. Prenatal diagnosis of thalidomide syndrome. Prenat Diagn, 7:295-298.
- Ito T, et al. 2020. Molecular mechanisms of thalidomide and its derivatives. Proc Jpn Acad Ser B Phys Biol Sci, 96(6):189-203.
- Klein-Weigel PF, Ding-Greiner C. 2025. Cardiovascular manifestations of thalidomide embryopathy. Vasa, 54(5):299-304.
- Mahesri M, et al. 2024. Trends in use and evidence of adherence to risk evaluation and mitigation strategy pregnancy testing requirements for thalidomide, lenalidomide, and pomalidomide in the USA, 2000-2020. Drug Saf, 47(9):909-919.
- Miller MT, et al. 2009. Thalidomide and misoprostol: opthalmologic manifestations and associations both expected and unexpected. Birth Defects Res A Clin Mol Teratol, 85(8):667-676.
- Peng X, et al. 2017. Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients. Medicine (Baltimore), 96(21):e6540.
- Prescriber Guide to (THALOMID REMS™ ) Risk Evaluation and Mitigation Strategy (REMS)™ Program. (2014). Retrieved from https://www.fda.gov/media/79047/download
- Rodier PM, 2000. The early origins of autism. Scientific American, 282:56-63.
- Rodier PM. 2002. Converging evidence for brain stem injury in autism. Dev Psychopathol, 14(3):537-557.
- Smithells R. 1992. Recognition of thalidomide defects. J Med Genet, 29:716-723.
- Sterling D, et al. 1997. Thalidomide: a surprising recovery. J Am Pharm Assn, 3:306-313.
- Stromland K, et al. 1993. Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmol (Copen), 71:238-245.
- Stromland K, et al. 1994 Autism in the thalidomide embryopathy: a population study. Dev. Med. Child Neurol, 36:351-356.
- Vargesson N. 2019. The teratogenic effects of thalidomide on limbs. J Hand Surg Eur Vol, 44(1):88-95.
- Xiang P, et al. 2023. Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study. J Ovarian Res, 16(1):34.
